Tag Archives: rituximab
Time to switch? Switching from innovator rituximab to biosimilar CT-P10 is safe and efficacious
Rituximab is a monoclonal antibody that targets the CD20 protein that is found mainly on immune cells called B lymphocytes. By removing CD20-positive B lymphocytes from the peripheral blood and bone marrow, rituximab provides effective treatment for
Long-term safety and efficacy of rituximab biosimilar CT-P10 in rheumatoid arthritis
Rituximab is a monoclonal antibody used to treat certain cancers of the blood, as well as immune-mediated diseases such as rheumatoid arthritis. But while rituximab is effective, it is also expensive, which means that not everyone who
Summary of: Screening for viral hepatitis prior to rituximab chemotherapy
There are an estimated 800,000-1.4 million people with Hepatitis B Virus (HBV) in the US. Patients with a low immune systems, such as cancer patients, are at an increased risk of reactivation of HBV if they have
